Dynamic contrast-enhanced, extremity-dedicated MRI identifies synovitis changes in the follow-up of rheumatoid arthritis patients treated with rituximab.

Creators: Parodi M; Zampogna G; Boesen M; Kubassova O; BARBIERI, FRANCESCA; Paparo F; Cutolo M.

Others:: Parodi, M; Zampogna, G; Boesen, M; Kubassova, O; Barbieri, Francesca; Paparo, F; Cutolo, M.

Description

The aim of this study is to assess prospectively the effect of rituximab (RTX) on MRI features of wrist joint disease in patients affected by rheumatoid arthritis (RA).

Dynamic contrast-enhanced, extremity-dedicated MRI identifies synovitis changes in the follow-up of rheumatoid arthritis patients treated with rituximab.

Description

Additional details